antibody

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

antibody

Jul 11, 2024, 06:26 | Insight

The Role of Antibody-Drug conjugates (ADCs) in Bladder Cancer

Bladder Cancer Advocacy Network shared on X: "Get practical guidance on using antibody–drug conjugates in…

Oct 29, 2023, 16:16 | Dialogues

5 min OncoDaily Updates with Chandler Park: Dr. Grivas on the 1st clinical study of 2 different antibody drug conjugates

[embed]https://www.youtube.com/watch?v=kc06AUL3gCA[/embed]

Jun 18, 2023, 16:32 | Drugs

FDA approved our new bispecific antibody for treating people with relapsed or refractory Diffuse Large B-cell Lymphoma

In a post by Alexander Hardy on Linkedin, it says, "I’m excited to share that…

May 14, 2023, 09:34 | Drugs

Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions - The ASCO Post

Quoting from ASCO Post, "Amivantamab-vmjw, an EGFR and MET bispecific monoclonal antibody, has demonstrated encouraging…

All: 4 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023